2221 - 2230 of 6570 Results
Title
Year
-
OPENTitle: Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 24Issue #: 3Start Page: 269End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717001011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5820218Citation Count: 21
-
OPENTitle: Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological StudyJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 4Start Page: 322End Page: 331Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000017Best OA location URL: http://doi.org/10.1017/S1355617717000017Citation Count: 21
-
OPENTitle: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 responseJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 102Issue #: 4Start Page: 1093End Page: 1102Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rrBest OA location URL: https://jlb.onlinelibrary.wiley.com/doi/pdfdirect/10.1189/jlb.1A0417-147RRCitation Count: 31
-
OPENTitle: LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infectionJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 214Issue #: 10Start Page: 3051End Page: 3066Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20170014Best OA location URL: https://rupress.org/jem/article-pdf/214/10/3051/1166015/jem_20170014.pdfCitation Count: 168
-
OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: http://doi.org/10.1016/j.pnpbp.2016.05.004Citation Count: 27
- Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease2014OPENTitle: Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson DiseaseJournal Name: The Journals of Gerontology Series A: Biological Sciences and Medical SciencesPublisher: Oxford University Press (OUP)Vol: 69Issue #: 12Start Page: 1569End Page: 1575Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/gerona/glu070Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/69/12/1569/9705604/glu070.pdfCitation Count: 15
- Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists2008OPENTitle: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 51Issue #: 18Start Page: 5506End Page: 5521Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm8002153Citation Count: 25
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor Antagonists2010OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pCitation Count: 85
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qCitation Count: 61
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3302577Citation Count: 140